Simplex Trading’s Agile Therapeutics AGRX Stock Holding History

Simplex Trading’s Portfolio AGRX Stock Details AGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-7	Closed	-$2K	–	11545
2022 Q1	$2K	Sell	7 -3	-30%	-$1.92K	﹤0.01%	9991
2021 Q4	$9K	Buy	10 +7	+233%	+$9.87K	﹤0.01%	9161
2021 Q3	$8K	Hold	3	–	–	﹤0.01%	9085
2021 Q2	$7K	Buy	+3	New	+$9.89K	﹤0.01%	9330
2021 Q1	–	Hold	0	–	–	–	4906
2020 Q4	–	Hold	0	–	–	–	5456
2020 Q3	–	Hold	0	–	–	–	4231
2020 Q2	–	Hold	0	–	–	–	4451
2020 Q1	–	Hold	0	–	–	–	5609
2019 Q4	–	Hold	0	–	–	–	4845
2019 Q3	–	Hold	0	–	–	–	5260
2019 Q2	–	Hold	0	–	–	–	4516
2019 Q1	–	Hold	0	–	–	–	5160
2018 Q4	–	Hold	0	–	–	–	6647
2018 Q2	–	Hold	0	–	-$4K	–	8056
2018 Q1	–	Hold	0	–	–	–	4872
2017 Q4	–	Hold	0	–	–	–	4589

Other funds holding AGRX

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Simplex Trading's AGRX Position: Q2 2022 in Review

Simplex Trading held its Agile Therapeutics (AGRX) position steady in Q2 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #11546.

Simplex Trading first reported a position in AGRX in Q3 2017 and has held it in 8 quarters since. The position peaked at $39K in Q4 2019. 19 funds tracked by Wall St. Rank hold AGRX as of Q2 2022.

Simplex Trading held 0 shares of Agile Therapeutics worth $0 as of Q2 2022.
Simplex Trading left its Agile Therapeutics share count unchanged in Q2 2022.
Agile Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2022, its #11546 holding.
Simplex Trading first reported a position in Agile Therapeutics in Q3 2017 and has held it in 8 quarters since.
Simplex Trading's Agile Therapeutics position peaked at $39K in Q4 2019.
19 funds tracked by Wall St. Rank held Agile Therapeutics as of Q2 2022.

Based on Simplex Trading's 13F filing for Q2 2022, filed 3 Aug 2022.